A comparison of the antifibrillatory effect of midazolam and flunitrazepam in acute myocardial ischaemia in the dog

Summary A study was carried out using a model of myocardial ischaemia in the dog after ligation of the left coronary artery to determine the effects of the benzodiazepines, flunitrazepam and midazolam, on the ventricular fibrillation threshold. The fibrillation threshold was measured twice within 15...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current medical research and opinion 1987, Vol.10 (8), p.527-530
Hauptverfasser: Hess, L., Vrána, M., Vránová, Z., Fejfar, Z.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 530
container_issue 8
container_start_page 527
container_title Current medical research and opinion
container_volume 10
creator Hess, L.
Vrána, M.
Vránová, Z.
Fejfar, Z.
description Summary A study was carried out using a model of myocardial ischaemia in the dog after ligation of the left coronary artery to determine the effects of the benzodiazepines, flunitrazepam and midazolam, on the ventricular fibrillation threshold. The fibrillation threshold was measured twice within 15 min and 8 min after ligation. Fifteen minutes after the onset ofischaemic heart attack, 1.2 mg midazolam/kg or 0.25 mg flunitrazepam and midazolam, on the ventricular fibrillation threshold. The fibrillation threshold was measured twice within 15 min and 8 min after ligation. Fifteen minutes after the onset ofischaemic heart attack, 1.2 mg midazolam/kg or 0.25 mg of ischaemia. Their effects on haemodynamics were negligible. It is suggested that both benzodiazepines can be used for increasing electrical stability of the heart in patients with acute myocardial infarction and to inhibit the psychic stress response. Because of its short biological half-life and water solubility, allowing painless intravenous administration, midazolam offers a more flexible approach to pharmacotherapy immediately after acute heart attack according to the patient's current clinical status.
doi_str_mv 10.1185/03007998709108961
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_81116884</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>81116884</sourcerecordid><originalsourceid>FETCH-LOGICAL-c316t-ebdf3bacd86572687082ad33af4c3078b09ac3d2ea04d942732354b88a377c543</originalsourceid><addsrcrecordid>eNp9kE9r3DAQxUVJSTdpP0APBZ1ycytZtiWTXEJom0Kgl_YsxvrTVZCsrSQTNp8-MrsEQiCngfm995h5CH2m5Culov9GGCF8HAUnIyViHOg7tKEdZ00nOD9Bm5U3VdB_QGc53xNCWzGOp-iUDZxzwTcoX2MVww6Sy3HG0eKyNRjm4qybkvMeSkx7bKw1qqw4OA2P0UOoIo2tX2ZXEjyaXd24GYNaisFhHxUk7cBjl9UWTHCw0jVbx38f0XsLPptPx3mO_v74_ufmtrn7_fPXzfVdoxgdSmMmbdkESouh5-1QnxQtaMbAdooRLiYygmK6NUA6PXYtZy3ru0kIYJyrvmPn6OKQu0vx_2JykaGeY-pTs4lLloJSOgixCulBqFLMORkrd8kFSHtJiVyLlq-Krp4vx_BlCkY_O47NVn514G62MQV4iMlrWWDvY7IJZuWyZG_FX76wbw34sq2tGnkflzTX3t447gmB0Z99</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>81116884</pqid></control><display><type>article</type><title>A comparison of the antifibrillatory effect of midazolam and flunitrazepam in acute myocardial ischaemia in the dog</title><source>MEDLINE</source><source>Taylor &amp; Francis Medical Library - CRKN</source><source>Taylor &amp; Francis Journals Complete</source><creator>Hess, L. ; Vrána, M. ; Vránová, Z. ; Fejfar, Z.</creator><creatorcontrib>Hess, L. ; Vrána, M. ; Vránová, Z. ; Fejfar, Z.</creatorcontrib><description>Summary A study was carried out using a model of myocardial ischaemia in the dog after ligation of the left coronary artery to determine the effects of the benzodiazepines, flunitrazepam and midazolam, on the ventricular fibrillation threshold. The fibrillation threshold was measured twice within 15 min and 8 min after ligation. Fifteen minutes after the onset ofischaemic heart attack, 1.2 mg midazolam/kg or 0.25 mg flunitrazepam and midazolam, on the ventricular fibrillation threshold. The fibrillation threshold was measured twice within 15 min and 8 min after ligation. Fifteen minutes after the onset ofischaemic heart attack, 1.2 mg midazolam/kg or 0.25 mg of ischaemia. Their effects on haemodynamics were negligible. It is suggested that both benzodiazepines can be used for increasing electrical stability of the heart in patients with acute myocardial infarction and to inhibit the psychic stress response. Because of its short biological half-life and water solubility, allowing painless intravenous administration, midazolam offers a more flexible approach to pharmacotherapy immediately after acute heart attack according to the patient's current clinical status.</description><identifier>ISSN: 0300-7995</identifier><identifier>EISSN: 1473-4877</identifier><identifier>DOI: 10.1185/03007998709108961</identifier><identifier>PMID: 3677787</identifier><language>eng</language><publisher>England: Informa UK Ltd</publisher><subject>animal ; Animals ; Anti-Arrhythmia Agents ; Coronary Vessels ; disease models ; Dogs ; flunitrazepam ; Flunitrazepam - pharmacology ; Heart Ventricles ; Ligation ; Male ; Midazolam ; Midazolam - pharmacology ; myocardial infarction ; Myocardial Infarction - drug therapy ; ventricular fibrillation</subject><ispartof>Current medical research and opinion, 1987, Vol.10 (8), p.527-530</ispartof><rights>1987 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1987</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c316t-ebdf3bacd86572687082ad33af4c3078b09ac3d2ea04d942732354b88a377c543</citedby><cites>FETCH-LOGICAL-c316t-ebdf3bacd86572687082ad33af4c3078b09ac3d2ea04d942732354b88a377c543</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1185/03007998709108961$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1185/03007998709108961$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>314,780,784,4022,27921,27922,27923,59645,59751,60434,60540,61219,61254,61400,61435</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3677787$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hess, L.</creatorcontrib><creatorcontrib>Vrána, M.</creatorcontrib><creatorcontrib>Vránová, Z.</creatorcontrib><creatorcontrib>Fejfar, Z.</creatorcontrib><title>A comparison of the antifibrillatory effect of midazolam and flunitrazepam in acute myocardial ischaemia in the dog</title><title>Current medical research and opinion</title><addtitle>Curr Med Res Opin</addtitle><description>Summary A study was carried out using a model of myocardial ischaemia in the dog after ligation of the left coronary artery to determine the effects of the benzodiazepines, flunitrazepam and midazolam, on the ventricular fibrillation threshold. The fibrillation threshold was measured twice within 15 min and 8 min after ligation. Fifteen minutes after the onset ofischaemic heart attack, 1.2 mg midazolam/kg or 0.25 mg flunitrazepam and midazolam, on the ventricular fibrillation threshold. The fibrillation threshold was measured twice within 15 min and 8 min after ligation. Fifteen minutes after the onset ofischaemic heart attack, 1.2 mg midazolam/kg or 0.25 mg of ischaemia. Their effects on haemodynamics were negligible. It is suggested that both benzodiazepines can be used for increasing electrical stability of the heart in patients with acute myocardial infarction and to inhibit the psychic stress response. Because of its short biological half-life and water solubility, allowing painless intravenous administration, midazolam offers a more flexible approach to pharmacotherapy immediately after acute heart attack according to the patient's current clinical status.</description><subject>animal</subject><subject>Animals</subject><subject>Anti-Arrhythmia Agents</subject><subject>Coronary Vessels</subject><subject>disease models</subject><subject>Dogs</subject><subject>flunitrazepam</subject><subject>Flunitrazepam - pharmacology</subject><subject>Heart Ventricles</subject><subject>Ligation</subject><subject>Male</subject><subject>Midazolam</subject><subject>Midazolam - pharmacology</subject><subject>myocardial infarction</subject><subject>Myocardial Infarction - drug therapy</subject><subject>ventricular fibrillation</subject><issn>0300-7995</issn><issn>1473-4877</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9r3DAQxUVJSTdpP0APBZ1ycytZtiWTXEJom0Kgl_YsxvrTVZCsrSQTNp8-MrsEQiCngfm995h5CH2m5Culov9GGCF8HAUnIyViHOg7tKEdZ00nOD9Bm5U3VdB_QGc53xNCWzGOp-iUDZxzwTcoX2MVww6Sy3HG0eKyNRjm4qybkvMeSkx7bKw1qqw4OA2P0UOoIo2tX2ZXEjyaXd24GYNaisFhHxUk7cBjl9UWTHCw0jVbx38f0XsLPptPx3mO_v74_ufmtrn7_fPXzfVdoxgdSmMmbdkESouh5-1QnxQtaMbAdooRLiYygmK6NUA6PXYtZy3ru0kIYJyrvmPn6OKQu0vx_2JykaGeY-pTs4lLloJSOgixCulBqFLMORkrd8kFSHtJiVyLlq-Krp4vx_BlCkY_O47NVn514G62MQV4iMlrWWDvY7IJZuWyZG_FX76wbw34sq2tGnkflzTX3t447gmB0Z99</recordid><startdate>1987</startdate><enddate>1987</enddate><creator>Hess, L.</creator><creator>Vrána, M.</creator><creator>Vránová, Z.</creator><creator>Fejfar, Z.</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1987</creationdate><title>A comparison of the antifibrillatory effect of midazolam and flunitrazepam in acute myocardial ischaemia in the dog</title><author>Hess, L. ; Vrána, M. ; Vránová, Z. ; Fejfar, Z.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c316t-ebdf3bacd86572687082ad33af4c3078b09ac3d2ea04d942732354b88a377c543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>animal</topic><topic>Animals</topic><topic>Anti-Arrhythmia Agents</topic><topic>Coronary Vessels</topic><topic>disease models</topic><topic>Dogs</topic><topic>flunitrazepam</topic><topic>Flunitrazepam - pharmacology</topic><topic>Heart Ventricles</topic><topic>Ligation</topic><topic>Male</topic><topic>Midazolam</topic><topic>Midazolam - pharmacology</topic><topic>myocardial infarction</topic><topic>Myocardial Infarction - drug therapy</topic><topic>ventricular fibrillation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hess, L.</creatorcontrib><creatorcontrib>Vrána, M.</creatorcontrib><creatorcontrib>Vránová, Z.</creatorcontrib><creatorcontrib>Fejfar, Z.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current medical research and opinion</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hess, L.</au><au>Vrána, M.</au><au>Vránová, Z.</au><au>Fejfar, Z.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A comparison of the antifibrillatory effect of midazolam and flunitrazepam in acute myocardial ischaemia in the dog</atitle><jtitle>Current medical research and opinion</jtitle><addtitle>Curr Med Res Opin</addtitle><date>1987</date><risdate>1987</risdate><volume>10</volume><issue>8</issue><spage>527</spage><epage>530</epage><pages>527-530</pages><issn>0300-7995</issn><eissn>1473-4877</eissn><abstract>Summary A study was carried out using a model of myocardial ischaemia in the dog after ligation of the left coronary artery to determine the effects of the benzodiazepines, flunitrazepam and midazolam, on the ventricular fibrillation threshold. The fibrillation threshold was measured twice within 15 min and 8 min after ligation. Fifteen minutes after the onset ofischaemic heart attack, 1.2 mg midazolam/kg or 0.25 mg flunitrazepam and midazolam, on the ventricular fibrillation threshold. The fibrillation threshold was measured twice within 15 min and 8 min after ligation. Fifteen minutes after the onset ofischaemic heart attack, 1.2 mg midazolam/kg or 0.25 mg of ischaemia. Their effects on haemodynamics were negligible. It is suggested that both benzodiazepines can be used for increasing electrical stability of the heart in patients with acute myocardial infarction and to inhibit the psychic stress response. Because of its short biological half-life and water solubility, allowing painless intravenous administration, midazolam offers a more flexible approach to pharmacotherapy immediately after acute heart attack according to the patient's current clinical status.</abstract><cop>England</cop><pub>Informa UK Ltd</pub><pmid>3677787</pmid><doi>10.1185/03007998709108961</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0300-7995
ispartof Current medical research and opinion, 1987, Vol.10 (8), p.527-530
issn 0300-7995
1473-4877
language eng
recordid cdi_proquest_miscellaneous_81116884
source MEDLINE; Taylor & Francis Medical Library - CRKN; Taylor & Francis Journals Complete
subjects animal
Animals
Anti-Arrhythmia Agents
Coronary Vessels
disease models
Dogs
flunitrazepam
Flunitrazepam - pharmacology
Heart Ventricles
Ligation
Male
Midazolam
Midazolam - pharmacology
myocardial infarction
Myocardial Infarction - drug therapy
ventricular fibrillation
title A comparison of the antifibrillatory effect of midazolam and flunitrazepam in acute myocardial ischaemia in the dog
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T04%3A53%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20comparison%20of%20the%20antifibrillatory%20effect%20of%20midazolam%20and%20flunitrazepam%20in%20acute%20myocardial%20ischaemia%20in%20the%20dog&rft.jtitle=Current%20medical%20research%20and%20opinion&rft.au=Hess,%20L.&rft.date=1987&rft.volume=10&rft.issue=8&rft.spage=527&rft.epage=530&rft.pages=527-530&rft.issn=0300-7995&rft.eissn=1473-4877&rft_id=info:doi/10.1185/03007998709108961&rft_dat=%3Cproquest_pubme%3E81116884%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=81116884&rft_id=info:pmid/3677787&rfr_iscdi=true